BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Riaz F, Chen Q, Lu K, Osoro EK, Wu L, Feng L, Zhao R, Yang L, Zhou Y, He Y, Zhu L, Du X, Sadiq M, Yang X, Li D. Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway. J Cell Mol Med 2021;25:4073-87. [PMID: 33689215 DOI: 10.1111/jcmm.16376] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Panzarin C, Simino LAP, Mancini MCS, Ignácio-Souza LM, Milanski M, Torsoni MA, Torsoni AS. Hepatic microRNA modulation might be an early event to non-alcoholic fatty liver disease development driven by high-fat diet in male mice. Mol Biol Rep 2022. [PMID: 35048271 DOI: 10.1007/s11033-021-07072-8] [Reference Citation Analysis]
2 Sulaiman SA, Dorairaj V, Abdul Ghafar KN, Abdul Murad NA. Noncoding RNAs Interactions in Hepatic Stellate Cells during Hepatic Fibrosis. Livers 2021;1:263-85. [DOI: 10.3390/livers1040021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhu H, Chen H, Ding D, Wang S, Dai X, Zhu Y. The interaction of miR-181a-5p and sirtuin 1 regulated human bone marrow mesenchymal stem cells differentiation and apoptosis. Bioengineered 2021;12:1426-35. [PMID: 33904366 DOI: 10.1080/21655979.2021.1915672] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Jiang Z, Xia W, Dai G, Zhang B, Li Y, Chen X. MicroRNA miR-4709-3p targets Large Tumor Suppressor Kinase 2 (LATS2) and induces obstructive renal fibrosis through Hippo signaling. Bioengineered 2021;12:12357-71. [PMID: 34931960 DOI: 10.1080/21655979.2021.2002493] [Reference Citation Analysis]
5 Zhang Y, Wang Y, Xue J, Liang W, Zhang Z, Yang X, Qiao Z, Jiang Y, Wang J, Cao X, Chen P. Co-treatment with miR-21-5p inhibitor and Aurora kinase inhibitor reversine suppresses breast cancer progression by targeting sprouty RTK signaling antagonist 2. Bioengineered 2022;13:455-68. [PMID: 34967265 DOI: 10.1080/21655979.2021.2009410] [Reference Citation Analysis]
6 Ma H, Wang X, Liu X, Wang C, Gao X, Niu J. miR-654-5p Contributes to the Activation and Proliferation of Hepatic Stellate Cells by Targeting RXRα. Front Cell Dev Biol 2022;10:841248. [DOI: 10.3389/fcell.2022.841248] [Reference Citation Analysis]
7 Liu J, Li J, Ma Y, Xu C, Wang Y, He Y. MicroRNA miR-145-5p inhibits Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer. Bioengineered 2021;12:3240-51. [PMID: 34238129 DOI: 10.1080/21655979.2021.1945361] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
8 Lin S, Wen Z, Li S, Chen Z, Li C, Ouyang Z, Lin C, Kuang M, Xue C, Ding Y. LncRNA Neat1 promotes the macrophage inflammatory response and acts as a therapeutic target in titanium particle-induced osteolysis. Acta Biomater 2022;142:345-60. [PMID: 35151924 DOI: 10.1016/j.actbio.2022.02.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Mahmoudi A, Butler AE, Jamialahmadi T, Sahebkar A. The role of exosomal miRNA in nonalcoholic fatty liver disease. J Cell Physiol 2022. [PMID: 35137416 DOI: 10.1002/jcp.30699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Zou L, Shi C, Wang D, Cheng J, Wang Q, Wang L, Yang G. Long non-coding RNA-non-coding RNA activated by DNA damage inhibition suppresses hepatic stellate cell activation via microRNA-495-3p/sphingosine 1-phosphate receptor 3 axis. Bioengineered 2022;13:6150-62. [PMID: 35200103 DOI: 10.1080/21655979.2022.2037841] [Reference Citation Analysis]
11 Lv B, Liu X, Zhu X, Huang M. miR-382-5p promotes cell invasion in hepatocellular carcinoma by targeting PTEN to activate PI3K/Akt signaling pathway. World J Surg Oncol 2022;20:175. [PMID: 35655254 DOI: 10.1186/s12957-022-02638-7] [Reference Citation Analysis]
12 Ren L, Li J, Liu L, Wu W, Zhao D, Zhang K, Xin X, Yang L, Yin L. Resolving hepatic fibrosis via suppressing oxidative stress and an inflammatory response using a novel hyaluronic acid modified nanocomplex. Biomater Sci 2021;9:8259-69. [PMID: 34761752 DOI: 10.1039/d1bm01499d] [Reference Citation Analysis]
13 Li Y, Cen CQ, Liu B, Zhou L, Huang XM, Liu GY. Overexpression of circ PTK2 suppresses the progression of nonalcoholic fatty liver disease via the miR-200c/SIK2/PI3K/Akt axis. Kaohsiung J Med Sci 2022. [PMID: 35791807 DOI: 10.1002/kjm2.12568] [Reference Citation Analysis]
14 Riaz F, Chen Q, Lu K, Osoro EK, Wu L, Feng L, Zhao R, Yang L, Zhou Y, He Y, Zhu L, Du X, Sadiq M, Yang X, Li D. Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway. J Cell Mol Med 2021;25:4073-87. [PMID: 33689215 DOI: 10.1111/jcmm.16376] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
15 Yang Y, Ban D, Zhang C, Shen L. Downregulation of circ_0000673 Promotes Cell Proliferation and Migration in Endometriosis via the Mir-616-3p/PTEN Axis. Int J Med Sci 2021;18:3506-15. [PMID: 34522177 DOI: 10.7150/ijms.63564] [Reference Citation Analysis]
16 Liu Y, Liu Y, He W, Mu X, Wu X, Deng J, Nie X. Fibroblasts: Immunomodulatory factors in refractory diabetic wound healing. Front Immunol 2022;13:918223. [DOI: 10.3389/fimmu.2022.918223] [Reference Citation Analysis]
17 Tadokoro T, Morishita A, Masaki T. Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA. Int J Mol Sci 2021;22:8139. [PMID: 34360904 DOI: 10.3390/ijms22158139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Sun B, Hu N, Cong D, Chen K, Li J. MicroRNA-25-3p promotes cisplatin resistance in Non-small-cell lung carcinoma (NSCLC) through adjusting PTEN/PI3K/AKT route. Bioengineered 2021;12:3219-28. [PMID: 34266345 DOI: 10.1080/21655979.2021.1939577] [Cited by in F6Publishing: 1] [Reference Citation Analysis]